Sisk is set to secure a deal to finish crashed contractor ISG’s £200m vaccine manufacturing factory job on Teesside.

The contractor’s life sciences business is understood to be in advanced talks with client Fujifilm Diosynth Biotechnologies about finishing the job, known as Project Borealis.

A deal will come as welcome news to the subcontractors on the job hoping for a quick restart to ease some of the fall-out from ISG’s collapse.

It would be the first major ISG project to resume works in the wake of the contractor’s fall into administration nearly two weeks ago.

It offers hope to other subcontractors around the country waiting in the wings to see if their projects can get a quick restart before project teams break-up and move on.

The multi-platform bio-tech manufacturing facility on the FDB Billingham site is being delivered in two phases.

Work halted on the advanced phase 1 on Thursday 19th just as news broke that ISG was heading into administration.

All subcontractors packed up that afternoon, including Irish M&E contractor Jones Engineering, which is owned by Cathexis, also the owner of ISG before it was placed into administration with EY.

Since then Sisk and Fujifilm are understood to have been in talks about completing the project.

Assuming details can be agreed, it is hoped the job can restart next week.